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WE have shown previously that various pathological liver changes, including
malignant hepatoma with metastases can be produced in rats by intermittent
administration ofpyrrolizidine alkaloids throughout the life ofthe animals (Cook,
Duffy and Schoental, 1950; Schoental, Head and Peacock, 1954; Schoental
and Head,1955).
In view ofthe difficulty of assessing the degree ofmalignancy from microscopic
examination of liver lesions, in the absence of metastases, it seemed important to
obtain some other criteria which could throw light on their nature, such as their
progression or regression when the treatment is discontinued.
We now report the results of experiments in which essentially similar liver
lesions, includinghepatoma, developedinratswhichweretreatedforonlyrestricted
periods with the alkaloids and then were left without any further treatment till
death. The alkaloids used were: retrorsine and its N-oxide isatidine, tested
previously, and riddelliine, another pyrrolizidine alkaloid from Senecio riddellii,
not so far tested in rats.
In addition the effects of supplements of betaine and of high casein diet on
the development ofthe liver lesions were explored.
MATERIALS AND METHODS
Young Wistar rats, bred locally, were used. In the same way as inthe previous
experiments of this series the animals were housed in metal cages, 2 to 6per cage,
segregated by sex, and were given food and water, or the appropriate solutions,
ad libitum. Their "normal " diet consisted of commercial pellets, Shearer's Pig
Weaner Nuts No. 1 (for its composition see Schoental et al., 1954) replaced in
later stages ofthe experiment by M.R.C. Diet 41 (Bruce and Parkes, 1949). When
high casein diet was used this was given in the form of a powder obtained by
mixing:
Per cent
Unextracted casein (Glaxo) . . 75-0
Ground maize (Shearer) . . . 12.0
Dried yeast (Boots) . . . . 2-0
Salt mixture (Glaxo D.L.6) . . 4.5
Arachis oil (T. & H. Smith) . . 5.0
Cod liver oil (T. & H. Smith) . . 15
100.0
* Present address: Toxicology Research Unit, M.R.C. Laboratory, Woodmansterne Road,
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When "normal" diet was supplemented with betaine the latter was given
as a 1 per cent solution in tap-water, neutralised with dilute hydrochloric acid.
The alkaloids, retrorsine and isatidine, were the same crystalline compounds
as used in previous experiments. Crystalline riddelliine was a gift from Professor
Roger Adams who established its structure (Adams, Hamlin, Jelinek and Phillips,
1942). It is a cyclic ester of retronecine with riddelliic acid (Fig. 1).
For injection, the solutions ofthe alkaloids were freshly prepared in water and
neutralised with dilute hydrochloric acid. For feeding purposes stock solutions
similarlypreparedwerestoredinthe cold(about 5° C.)forshortperiods, anddiluted
when required.
All the experimental and control rats were weighed at approximately weekly
intervals. In some rats liver biopsies were performed under ether anaesthesia.
CH3 OH
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N
Riddelliine
FIG. 1.-Chemical formula for riddelliine.
A part of the presenting lobe was then removed for microscopic examination.
The animals that died orwere killedby chloroform whenmoribund, were examined
postmortem. Theliversandsomeotherorgans werethenfixedin" formalcorrosive"
for microscopic examination; sections were routinely stained with haematoxylin
and eosin; other fixatives andstains were used whenrequiredforspecial purposes.
EXPERIMENTAL
In Table I are summarised the treatments andsurvival times ofallthe animals.
Riddelliine
Fourteen female and 6 male rats on "normal" diet were given solutions
containing 0.02 mg./ml. of riddelliine in drinking water twice weekly during
6 months. Five of the females and 5 surviving males were then injected intra-
peritoneally with riddelliine, 25 mg./kg. body weight; 3 such injections were
given in the course ofone month. The remaining female rats continued to receive
solutions of the alkaloid. One year after the beginning of the experiment all the
surviving rats, 12 females and 4 males, were each injected intraperitoneally with
riddelliine 30 mg./kg. body weight and were left without further treatment till
death.
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TABLE I.--Survival ofRats Treated with Pyrrolizidine Alkaloids
No. ofrats which died
No. Less
of than 1-11 11-21
Alkaloid Diet rats Sex Dosage Route 1 year years years
Riddelliine . N . 14* . F. . 0.02mg./ml.+inj.. O.+I.P. . 2 4 8
25-30 mg./kg.
6* M. . Ditto . ,, . 2 3 1
Retrorsine . N . 2 . F. . 6 X25-30 mg./kg.. I.P . - 2
Bq+N . 2 . , .. ,, ,, ,. ,, .
- 2
Isatidine . N . 3 . M. . 0.2 mg./ml. . O. . 3 - -
B+N. 3 ,.. .. ,. ,,.. 3 -V 3
.9 7*. , . 0.03 mg./ml. . . 4 2 1
N . 6 . .5 x40-50 mg./kg. . I.P. . 3 2 1
C+N .6 ... . ,, . 2 1 3
N . 6 . . ,,,,,, . . 3 3 -
,, . 3 . . 5 X25-50 mg./kg .. . -- - 3
,, . 5 . M ....., ,, . ,, . 1 2 2
Controls .. 8 . . .. -- . - - 8
. 8 . F. . - . 8- . - - 8
B+N. 3 . M. . - - 3
All 82 . M.
and F.
N = "Normal" diet; B = betaine supplements; C = high casein diet; * - biopsies per-
formed; F. = females; M. = males; O. = oral; I.P. = intraperitoneal injections.
Liver biopsies were carried out on 2 ofthe male rats 2 months after treatment
was started and on microscopical examination anisocytosis was seen inboth livers.
This was more pronounced in one which showed areas of small basophil cells
containing muchglycogen alternatingwith areas oflargeeosinophilcells containing
lessglycogen. Manyof these cells had large nuclei and eosinophil inclusion bodies
were seen in the cytoplasm, but no fatty change was noted.
Little change was seen apart from congestion and dilatation of sinusoids in
biopsies after31 months and at 6 months some thrombosed blood vessels andfatty
change were noted.
One male rat was killed 4 months, and one died 11 months after treatment
started. In the liver ofthe former small pale microscopical nodules ofvacuolated
cells were seen adjacent to portal or hepatic veins and some vessels were throm-
bosed,andinthelatterareasofdegeneration andregenerationwereseenintheliver.
Ofthe 4 males which survived after one year of treatment, 1 died and 2 were
killed 6 months, and one 16 months after the last injection. The livers of all 4
rats were grossly abnormal, showing pale solid nodules and in 2 cystic areas were
also present. In the rat which died after 6 months the liver weighed 30 g. and
nodules were present in all the lobes, the largest (3 x 2.7 cm.) being in the left
half of the median lobe. Blood was present in the abdominal cavity. On micro-
scopicalexamination the liver showed nodular hyperplasia and fibrosis with areas
ofbile duct proliferation (Fig. 2). Many nodules had necrotic centres and areas of
haemorrhage.
The 2 male rats which were killed after 6 months had pale nodules in the liver
but fibrosis was not seen. Microscopically some of the nodules were composedREGINA SCHOENTAL AND MARY A. HEAD
of large vacuolated cells with faintly staining eosinophil cytoplasm. Binucleated
cells were common and some mitoses were noted. Some of the cells contained
phloxinophil inclusion bodies. These nodules usually had one side adjacent to
hepatic or portal veins. Other nodules were composed of foamy, fatty cells. In
one, a larger nodule composed of basophil cells with a trabecular arrangement
may be an early hepatoma (Fig. 3).
The fourth ratwhich was killed 16 months after the last injection had a nodular
liver, some nodules being pale and solid and others being cystic. The spleen and
kidneys were congested. Microscopically the nodules were similar to those seen
in the earlier cases but were larger and mitoses were more common. Much bile
duct hyperplasia was present round the portal systems and extending between
the liver cords. Multilocular bile duct cystadenomata were present. Pigmented
histiocyte-like cells were present in the hepatic veins similar to those seen in rats
treated with retrorsine and isatidine in previous experiments (Schoental, et al.,
1954). The kidneys and spleen in all 4 rats were congested and much pigment was
seen in the spleens. All the lungs showed areas of bronchiectasis.
Two female rats were killed 11 and 12 months after the start of treatment.
The former showed fatty change in the liver. A biopsy at 31 months had shown
only congestion. The latter showed microscopical nodules of small regenerating
cells and of large faintly staining granular cells. Areas of fatty change were also
noted. The spleen contained much stainable ironpigment and the kidneys showed
catarrhal change.
Twelve female rats died or were killed 3-17 months after the last injection of
the alkaloid. The livers were less severely affected than those of the male rats
which received similar treatment; 5 rats which died after 3-8 months showed
only slight congestion of the liver. In the livers of 6 female rat which died after
10-17 months, multilocular bile duct cysts were present and 5 had also small
yellow nodules. One rat had a sarcoma in the liver arising in the wall of a tape-
worm cyst, with metastases in the abdominal lymph nodes. The liver also showed
centrilobular necrosis with a zone of fatty change at the periphery of the lobules.
On microscopical examination the small yellow nodules in the liver were similar
to those seen in the male rats. They consisted of small regenerating cells, of pale
vacuolated granular cells and of foamy, fatty cells. The spleens contained much
pigment and the kidneys were congested in most of the rats. Bronchiectasis was
present in 9 animals, haemorrhage into the stomach in 2, a mammaryfibroadenoma
in 1, pyometra in 1 and a large abscess in the lower jaw in 1.
Retrorsine
Four female rats (100-120 g. body weight) were each given 6 injections of
retrorsine (25-30 mg./kg. body weight); 4 of these were given approximately at
weekly intervals during the first month and were followed by 2 injections given
every 2 months. Two ofthe rats were given solutions containing 1percentbetaine
instead ofdrinking water during 1 year beginning 24 hours before the first injection
of retrorsine. The latter 2 rats survived 28 and 29 months from the beginning of
the experiment, or 22 and 23 months respectively after the last injection of the
alkaloid. Both had grossly nodular livers, one of which contained a hepatoma
(Fig. 6, 7). All 4 rats had large multilocular cysts in the livers (Fig. 4, 5).
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The 2 female rats which received the same course of retrorsine injections but
did not receive betaine had only microscopic nodules in their livers when they
died 19 and 22 months respectively after the last injection of the alkaloid. The
growth rates of both groups of rats were almost identical till shortly before death
and not unlike those of female control rats, and the animals appeared to be in
good health for at least 2 years after the beginning of treatment.
Isatidine
Feeding
(a) Six male rats (60-70 g. body weight) were given solutions of isatidine
containing 0.2 mg./ml. instead of drinking water twice weekly during one month.
Three of these rats received additionally daily solutions of betaine beginning 24
hours before alkaloid treatment.
The 3 rats given only solutions of isatidine and 1 from the betaine-treated
group died less than 7 weeks after the beginning of the experiment. The livers
of these rats showed mostly centrilobular necrosis. Histiocyte-like cells were seen
in the hepatic veins and also in the small veins in the lungs which were congested.
The kidneys and spleens were also congested. Gastrointestinal haemorrhage was
present in the betaine-treated animal.
Two of the rats which received concurrently isatidine and betaine survived
31 and 4 months respectively. These remained stunted, sexually immature, and
developed striking anaemia and generalised oedema. Post mortem they were found
to havepleural and peritoneal effusions of serous fluid, the lungs showed haemor-
rhagic petechiae, the livers were shrunken, granular, the pancreases oedematous,
retroperitoneal lymph nodes were dark red, and the kidneys were dark brown.
Microscopical examination ofthe livers showed areas ofdegeneration andregenera-
tion. There was an increase in bile duct formation and some fibrosis. Stainable
iron pigment was present in the portal triads. There was great variation in the
size of the parenchyma cells. The features seen in these two rats were similar to
these described previously (Schoental, 1955).
(b) Seven male rats (50-100 g. body weight) were given solutions of isatidine
0 03 mg./ml. twice weekly and 1 per cent solution of betaine daily for about 1
year.
Liver biopsy specimens were taken 1 and 3 months after the beginning of
treatment. Two at 1 month showed some hyperplasia ofliver cells which formed
tortuous cords. Two at 3 months showed congestion of sinusoids with some
thrombosis of the central veins in one. One of the biopsied rats (256/54) died
after 3 months and showed necrotic tissue at the site of the previous biopsy, but
otherwise the liver architecture was normal.
The next rat (734/54) died after 61 months and had nodules in all lobes of the
liver, some about 2-3 mm. diameter. The other organs were congested and large
haemolymph nodes were seen in the omentum. Microscopically, numerous
nodules of hyperplasia were seen. Some with areas of degeneration in the centre
had a hepatoma-like appearance.
Rat 1171/54, killed after 101 months had a large smooth dark liver and showed
macroscopical iron reaction in the liver, spleen and lungs. On microscopical
examination the liver cells were large and swollen and some showed fatty change.
There was some thrombosis of blood vessels.
539REGINA SCHOENTAL AND MARY A. HEAD
Rat 1348/54 died after 1 year and nodules 2-3 mm. diameter were present
in all the lobes of the liver. Microscopically these were of two different types.
One was composed oflarge granular, vacuolated cells inwhichmitoses werepresent
and the other of small basophil cells. They were surrounded by flattened liver
cells.
Rat 716/55, 6 months after treatment ceased, had numerous nodules in all
lobes with almost no normal liver tissue. A large pale tumour-like mass was
present on the under-surface of the median lobe. Microscopically these showed
hyperplastic liver cells and some had hepatomatous appearance. Other areas
showed cystic bile duct formation and fibrosis was present round the nodules.
Rat 809/55 was killed 3 weeks later and had a large liver with several nodules
0.5-1 cm. diameter and cystic areas. The other organs were congested. Micro-
scopically the nodules were composed ofhyperplastic cells some probably hepato-
mata. Only a little fibrosis was present.
One rat (1091/55) had a large tumour-like area in the liver and a haemorrhagic
nodule in the omentum when it died 10 months after treatment stopped. The
tissues were autolytic but nodules of irregular hyperplasia could be made out
on section. The nodule inthe omentum contained giant cells surrounding a central
area ofhaemorrhage.
Intraperitoneal injections
(a) Twelve male and 6 female rats were given 5 injections of isatidine 40-50
mg./kg. body weight each in the course of the first 2 months of life, the first
injection being given before weaning when the rats were 17 days old.
Six of the male rats received from weaning the high casein diet for 6 months,
followed by "normal" diet till death. The other 6 males and 6 females were
given "normal" diet all their lives.
The 6 rats on the high casein diet survived from 10 to 23 months after the last
injection of the alkaloid.
EXPLANATION OF PLATES.
FIG. 2.-(525/55). Male rat 6 months after treatment with ridelliine had stopped. Nodular
hyperplasia and fibrosis. H. & E. x 25.
FIG. 3.-(533/55). Male rat 6 months after treatment with riddelliine had stopped. Part
of hepatoma-like nodule in upper right of field with flattened pernchyma cells in lower left
corner. H. & E. X 175.
FIG. 4.-(587/56). Female rat 22 months after the last subcutaneous injection of retrorsine.
Supplements of betaine were given during the first year. Large cysts are present in all
lobes and some solid, pale nodules.
FIG. 5.-(587/56). Section of multilocular cyst shown in Fig. 4. H. & E. 25.
FIGa. 6.-(706/56). Female rat 23 months after the last subcutaneous injection of retrorsine.
Supplements of betaine were given during the first year. A large yellow tumour-like
mass is present in the left lobe, small yellow nodules in the middle lobe, and cysts in the
right lobe.
FIG. 7.-(706/56). Section oftumour shown in Fig. 6 showing variation in structure-partly
solid and partly cystic. H. & E. x 22.
FIG. 8.-(812/55). Male rat 11 months after the last injection of isatidine. High casein diet
was given for the first 6 months of life. Fatty nodule. H. & E. x 135.
FIG. 9.-(744/56). Male rat 23 months after last injection of isatidine. High casein diet
given for first 6 months of life. Tumour cells are seen lining blood vessel. H. & E.
x 100.
FIG. 10.-(1306/56). Male rat 28 months after subcutaneous injection of isatidine. Fed on
"normal" diet. Hepatoma-like nodule with area of fibrosis at lower left corner of field.
H.&E. X 110.
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Two which died after 10 months showed only slight congestion of the liver.
Two died after 22 and 23 months and showed thrombosis of bloodvessels, dilated
sinusoids and cystic spaces containing granular eosinophil material.
The remaining 2 rats showed more severe damage.
The first (812/55) was killed after 11 months and had alarge liver with nodules
in all the lobes and some cystic areas on the surface. Microscopically the nodules
had the appearance of trabecular hepatomata with flattened liver cells around
them and no fibrosis. Other nodules were composed offatty cells (Fig. 8).
The second (744/56) died after 23 months and a large tumour-like nodular
mass was present in the left lobe of the liver. Small yellow areas were seen in the
other lobes and a cyst in the caudal lobe. Microscopically the lesions appeared
to be of endothelial rather than hepatic cell origin and were similar to those
described in previous experiments (Schoental et al., 1954) in rats treated with
isatidine (Fig. 9). Thrombosed blood vessels were seen and large endothelial
cells lining blood vessels. Large cystic blood spaces were also noted.
Ofthe 6 male rats on normaldiet, 3 survivedfrom 12 to 28 months afterthelast
injection. Only congestion ofthe liver was seen in the 3 which died before 1 year.
Two which died after 12 and 19 months showed little change in the liver apart
from some congestion of the sinusoids. The third (1306/56) died after 28 months
and 2 tumour-like nodules about 1 cm. diameter were seen in the right and median
lobes of the liver. Microscopically these were composed of trabeculae of hepatic
cells. Some fibrosis was seen around the nodules (Fig. 10).
Of the 6 female rats on normal diet 3 survived from 10 to 18 months after the
last injection. The first 2 showed congestion of internal organs, anc the third,
small nodules, some of which appeared to be early heapatomata. One of these
extendedthroughthewallofaportalvein andthe cellslinedthelumenofthevessel
at this area.
(b) Three female rats (125-155 g. body weight) received 5 intraperitoneal
injections ofisatidine, 25 to 30 mg./kg. spread over 2 months and were left without
further treatment till they died 18 to 29 months later.
One which died after 20 months showed some small nodules of hyperplasia
and a multilocular bile duct cyst. The 2 others showed some cellular infiltration
of the portal triads.
Five male rats on the same series died 9-25 months after the last injection.
Rat 275/55 died 9 months after treatment ceased and the liver had nodules in
all lobes, bronchiectasis and abscesses in kidney and heart wall were present.
Microscopically degeneration and fibrosis with hyperplasia of the remaining
liver cells were noted. Some liver cells were lying singly and others formed small
nodules. Rat 746/55 died 13 months after treatment stopped and had a small
cirrhotic liver, 6.5 g. The kidney showed pyonephrosis and the bladder contained
10 stones, the largest 3 mm. diameter, composed of calcium carbonate. Micro-
scopically the liver showed nodular hyperplasia and fibrosis.
Rat 1292/55, killed after 18 months, had a large pale liver with one large
nodule in the middle lobe. On miroscopical examination there were nodules of
hyperplasia with bands of fibrous tissue around them. One nodule was 5 mm. in
diameter and was composed of irregular trabeculae of large hepatic cells and
surrounded by flattened liver cells and fibrous tissue.
Rat 340/56 which died 21 months after the last injection had a dark congested
liver with ayellownodule inthe leftlobe and some haemorrhage into the abdominal
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cavity. Microscopically all the organs showed much congestion of blood vessels.
An area of infarction was present in the liver and a round nodule composed of
congested dilated sinusoids with narrow cords of liver cells between them.
Rat 837/56 was killed 25 months after the last injection and the liver showed
cystic and yellow areas. Microscopically a multilocular bile duct cyst and a hyper-
plastic nodule of liver cells were seen.
Controls
Eight male and 7 female rats were kept as controls and received "normal"
diet. Liver biopsies were performed on 2 females aged 7 weeks and 3- months
respectively and no architectural abnormalities were found. All control rats
survived from 18 to 33 months and showed no cirrhosis, hyperplasia, or tumours
of the liver. Seven had extensive bronchiectasis. Three rats had abscesses in
uterine horn, jaw, andmiddle earrespectively. One hadamammary fibroadenoma,
and I an ovarian tumour with metastases. Three male rats were given "normal"
diet supplemented with a 1 per cent solution of betaine instead of drinking water
for 1 year. These survived 22-29 months. No abnormalities were seen in their
livers.
DISCUSSION
Rosenberg and Beath (1945) described acute hepatotoxic effects of riddelliine
in mice injected intraperitoneally (100-500 mg./kg. body weight), as well as more
chronic lesions due to feeding the dried, ground plant of Senecio riddellii. In the
present experiments riddelliine was tested in rats in which it produced nodular
hyperplasia, fibrosis and primary liver tumours. In rats, lesions produced by
riddelliine were very similar to those due to other pyrrolizidine alkaloids and
developedin animals which appeared in good health duringthe period oftreatment
and for many months after the treatment was discontinued. A notable feature
was the great variation of the amount of fibrous tissue in livers of individual
animals surviving the same time after the treatment with riddelliine and the
greater susceptibility of males than females to the action of this alkaloid. The
same was observed with the otherpyrrolizidine alkaloids, retrorsine and isatidine.
It is well known how difficult it is to diagnose liver tumours and to assess their
degree of malignancy, in the absence of metastases (e.g. Opie, 1944; Magee and
Barnes, 1956). Usually authors decide on their own critieria ofclassification which
makes it difficult to compare datafromdifferent laboratories. Some more objective
critieria are greatly desirable.
Thepresent experiments may serve such a purpose. The treatmentwas stopped
at a time when liver lesions were likely to have developed but were still very slight
when examined in biopsy specimens and the animals were allowed to live as long
as possible. This procedure showed whether and to what extent the lesions are
reversible.
The results show that liver lesions produced by pyrrolizidine alkaloids, retror-
sine, riddelliine, and isatidine, are irreversible and progressive. Even in the
absence of further treatment the changes present in the livers became more
accentuated with time, fibrous tissue if present became more prominent, hyper-
plastic nodules tended to increase in size, mitotic figures became niore numerous
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while characteristic large parenchymal cells persisted throughout the lifespan of
the animals. Althoughno metastases were seeninthepresentseries ofanimals some
of the liver lesions were distinctly hepatomata. These were found sometimes in
livers in which fibrotic changes were not prominent and also in those in which
fibrosis was present. Similar lesions have been shown previously to lead to malig-
nant tumours with metastasis (Schoental et al., 1954) and in view oftheir progres-
sive nature it seems justified to consider these as neoplastic. However the long
survival of the animals in apparent good health does not suggest a high degree of
malignancy.
The role ofnutrition inrelation toliver damaging agents in general (Drill, 1952)
and to liver carcinogens such as azo-dyes inparticular has beenextensively studied
(Miller and MAiller, 1955). Only a few dietary factors have as yet been investigated
in conjunction with pyrrolizidine alkaloids. While protein deficiency has been
shown to have a deleterious effect on the survival time ofthe animals treated with
pyrrolizidine alkaloids (Selzer, Parker and Sapeika, 1951; Schoental and Magee,
1957) in the present pilot experiment high casein diet favoured longer survival of
rats and also the development ofliver tumours. While choline deficiency is known
toproducelivertumours (Copeland and Salmon, 1946), supplementation ofnormal
diet with choline failed to inhibit the development oftumours due to pyrrolizidine
alkaloids (Schoental et al., 1954). It seemed of interest to test whether this lack
of action of choline was not due to inactivation of the enzyme, choline oxidase,
concerned with the oxidation of choline to betaine, an essential step in the mecha-
nism of transmethylation (Dubnoff, 1949). Asano (1955) reported decrease of
choline oxidase in liver tumours.
In a pilot experiment the effect of supplementing the "normal" diet with
betaine was therefore tested. The results show clearly that betaine, like choline,
failed to inhibit, and may have even favoured the development of liver tumours
in our animals. It is ofinterest to note that rats receiving supplements ofbetaine
were not protected against the more acute changes such as anaemia, subcutaneous
oedema, gastro-intestinal haemorrhage, pancreatic abnormalities and the corres-
ponding early liver lesions.
The irreversible character of the liver lesions demonstrated by the present
experiments illustrates the dangerous potentialities ofpyrrolizidine alkaloids when
ingested even in doses which may have no immediate effects on the health of the
individual. They also underline the obvious difficulty in tracing the causative
agents, when confronted with fully developed chronic liver lesions in animals or
men.
SUMMARY
Various liver lesions including liver tumours developed in rats which survived
in apparent good health many months afterthe cessation ofa temporary treatment
with the pyrrolizidine alkaloids; riddelliine, retrorsine and isatidine.
Neitherhigh casein diet nor supplements ofbetaine prevented the development
of the various liver lesions.
We wish to thank Dr. P. R. Peacock, the Director of Research, for his interest
in this work, Mr. S. Breslin and Mr. C. Bern for the photographs, and the Staffof
the Department for their valuable assistance.
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For the generous gifts of the alkaloids we are greatly indebted to Professor
Roger Adams, University of Illinois, Urbana, (riddelliine), and Professor F. L.
Warren, University ofNatal, Pietermaritzburg, (retrorsine and isatidine).
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